Oncogenic DDX46 promotes pancreatic cancer development and gemcitabine resistance by facilitating the JMJD6/CDK4 signaling pathway / Guang Yang ... [et al.]. Neoplasma Vol. 71, no. 3 (2024), s. 231-242